BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for ContraFect Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-19 5:13 pm Sale | 2022-07-15 | 13G | ContraFect Corporation CFRX | BIOTECHNOLOGY VALUE FUND L P | 23,091 4.500% | -26,563 (-53.50%) | Filing |
| 2021-04-15 4:06 pm Purchase | 2021-04-13 | 13G | ContraFect Corporation CFRX | BIOTECHNOLOGY VALUE FUND L P | 49,654 10.100% | 13,292 (+36.56%) | Filing |
| 2020-10-20 08:59 am Purchase | 2020-05-22 | 13G | ContraFect Corporation CFRX | BIOTECHNOLOGY VALUE FUND L P | 36,361 9.990% | 36,361 (New Position) | Filing |